|
Report
Number
|
Description
|
Category
|
Date
Issued
|
|
47
|
Rx-360 Summary of the U.S. FDA Guidance on Residual Solvents |
Guidance
|
29-Dec-09
|
|
36
|
Rx-360 Summary of the U.S. FDA’s Guidance on Melamine Contamination |
Guidance
|
09-Aug-09
|
|
35
|
Rx-360 Summary of the U.S. FDA Issues Pharmaceutical Industry Guidance on Preventing Melamine Contamination |
Guidance
|
06-Aug-09
|
|
30
|
Rx-360 Summary of US FDA's Draft Guidance for Industry on PCIDs |
Guidance
|
21-Jul-09
|
|
28
|
Rx-360 Summary of the U.S. FDA Issues Draft Guidance for Industry on Drug Anti-counterfeiting |
Regulation
|
14-Jul-09
|
|
22
|
Rx-360 Summary of the U.S. Congressman Dingell's New US Draft Legislation HR 759 |
Legislative
|
16-Jun-09
|
|
18
|
Rx-360 Summary of the new US Congress Draft Legislation on Supply Chain Security |
Legislative
|
01-Jun-09
|
|
7
|
Rx-360 Summary of the U.S. draft US Senate Drug Device Accountability Act of 2009 – Rx-360 Analysis |
Legislative
|
05-May-09
|
|
3
|
Rx-360 Summary of the U.S. Announcement of US Drug and Device Accountability Act of 2008 |
Legislative
|
30-Apr-09
|